Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival

The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials

(2012) Ye-min Wang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?

(2011) K. H. Allison et al.   BREAST CANCER RESEARCH AND TREATMENT

Triple-negative breast cancer in Hispanic patients

(2011) Fernando Lara-Medina et al.   CANCER

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

(2011) M. D. Mediavilla et al.   CURRENT MEDICINAL CHEMISTRY

Melatonin as Adjuvant Cancer Care With and Without Chemotherapy

(2011) Dugald Seely et al.   INTEGRATIVE CANCER THERAPIES

Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer

(2011) Steven M. Hill et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night

(2011) David E. Blask et al.   JOURNAL OF PINEAL RESEARCH

Shift work and cancer – considerations on rationale, mechanisms, and epidemiology

(2011) Giovanni Costa et al.   SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH

Proliferation (Ki-67 and Phosphohistone H3) and Oncotype DX Recurrence Score in Estrogen Receptor-positive Breast Cancer

(2011) Daron J. Williams et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

In vitro and in vivo antitumor activity of melatonin receptor agonists

(2010) Lulu Mao et al.   JOURNAL OF PINEAL RESEARCH

Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)

(2010) Anna Leja-Szpak et al.   JOURNAL OF PINEAL RESEARCH

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors

(2010) M. L. Dubocovich et al.   PHARMACOLOGICAL REVIEWS

Molecular Mechanisms of Melatonin Anticancer Effects

(2009) Steven M. Hill et al.   INTEGRATIVE CANCER THERAPIES

Light-at-night, circadian disruption and breast cancer: assessment of existing evidence

(2009) R. G Stevens   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells

(2009) Rainer Girgert et al.   JOURNAL OF PINEAL RESEARCH

Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

(2008) Ling Lai et al.   BREAST CANCER RESEARCH AND TREATMENT

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

(2008) Mary Jo Lund et al.   BREAST CANCER RESEARCH AND TREATMENT

High prevalence of triple-negative tumors in an urban cancer center

(2008) Mary Jo B. Lund et al.   CANCER

Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma

(2008) Erina Nakamura et al.   CANCER SCIENCE

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

(2008) Silvia Rivara et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET